Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
1. Inclusion Criteria:~   a. Patients who are 18 years of age and older, and who agreed to participate in the study will be included in the study.~2. Exclusion Criteria:~   1. Patients having received analgesic in the last six hours,~  2. pregnant women,~  3. women of childbearing potential and not using birth control,~  4. those who do not agree to participate in the study,~  5. those under age of 18, those who have signs of peritoneal irritation,~  6. those who are allergic to drugs used in the study,~  7. hemodynamically unstable patients,~  8. patients with renal transplant,~  9. those who suffer from liver, kidney, cardiac and pulmonary insufficiency and others with systemic diseases,~  10. patients with vision problems and those who are illiterate will be excluded from the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Paracetamol (Type: EXPERIMENTAL): Paracetamol which will be given after randomization will be diluted in serum physiologic and will be given as intravenous rapid infusion.
- Dexketoprofen (Type: ACTIVE_COMPARATOR): Dexketoprofen which will be given after randomization will be diluted in serum physiologic and will be given as intravenous rapid infusion.

Based on this trial design, predict the completion outcome and termination type (if applicable).